Skip to main content
. 2021 Oct 9;24(2):209–213. doi: 10.4103/jcd.jcd_97_21

Table 2.

Global assessment of efficacy and tolerability in three study groups

Total (n=30), n (%) Yogic relaxation (n=10), n (%) Alprazolam (n=10), n (%) Placebo (n=10), n (%) P
Global assessment of efficacy
 Excellent 12 (40) 9 (90) 2 (20) 1 (10) 0.000
 Good 5 (16.7) 1 (10) 4 (40) 0
 Moderate 6 (20) 0 3 (30) 3 (30)
 Poor 7 (23.3) 0 1 (10) 6 (60)
Global assessment of tolerability
 Excellent 24 (80) 9 (90) 7 (70) 8 (80) 0.535
 Good 6 (20) 1 (10) 3 (30) 2 (20)